The new project is advancing biomarkers that would improve the care of people living with HIV and hepatitis D, plus stem cell transplant patients at risk of cytomegalovirus (CMV).
The new project is advancing biomarkers that would improve the care of people living with HIV and hepatitis D, plus stem cell transplant patients at risk of cytomegalovirus (CMV).
A roundup of some recent IMI cancer progress stories, and cancer-related projects launched in 2021
The new project plans to use a big data approach, powered by cutting-edge artificial intelligence and machine learning, to improve the care of people with knee osteoarthritis.
The new IHI project aims to deliver tools and resources to facilitate the set-up and conduct of trials for rare and ultra-rare diseases while minimising the burden for patients.
Regulatory sandboxes allow innovators and regulators to explore how best to regulate a new technology so that end users are protected, while innovations are not held back.
Discover how our projects are having a real impact on research in diverse areas.
The GRIPonMASH project aims to transform the way we detect and diagnose a common, but little-known, liver condition dubbed MASLD.
Our governance structure ensures that IHI benefits from the input of a diverse range of stakeholders.
While the incidence of Alzheimer’s disease continues to grow at an alarming rate, advances in treatment and prevention have stalled. IMI's ADAPTED project worked to better...